New pill could cure disfiguring skin disease in months
⭐️ CURE ⭐️
Not yet recruiting
This study tests two different doses of an experimental oral drug, LXE408, against a standard treatment (miltefosine) for localized cutaneous leishmaniasis, a parasitic skin infection. About 250 adults with up to six skin sores will receive one of the treatments for several weeks…
Phase: PHASE2 • Sponsor: Drugs for Neglected Diseases • Aim: ⭐️ CURE ⭐️
Last updated May 09, 2026 04:34 UTC